In particular, our findings indicate that an extensively studied biomarker such as fibronectin exhibits opposite expression patterns in small‐EVs in response to chemotherapy when measured in bulk ascites on the total pool of small‐EVs or specifically in the cultures of patients' tumor cells. Here, FN1 is linked to neoplasm.